Symbol
| ADAM9
| contributors: mct/pgu - updated : 30-01-2017
|
HGNC name
| ADAM metallopeptidase domain 9 (meltrin gamma)
|
HGNC id
| 216
|
corresponding disease(s)
|
CORD12
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in breast carcinoma, node-positive | tumoral
|  
|  
| --over
|  
|
in non-small cell lung cancer correlates with brain metastasis | tumoral
|  
|  
| --over
|  
|
in gastric carcinoma, and pancreatic cancer | |
Susceptibility
|
to sporadic Alzheimer disease (SAD) |
Variant & Polymorphism
other
| promoter polymorphisms which regulate ADAM9 transcription are protective against SAD  |
|
|
Candidate gene
| may be a valid target for gene therapy (Parry 2009) |
|
attractive target for the prevention of proliferative retinopathies, choroidal neovascularization, and cancer  |
|
|
Marker
Therapy target
| | |
| overexpressed in breast carcinoma, node-positive | |
progressive degeneration affecting both rods and cones in Adam9−/− mice  |